An NCI-designated Comprehensive Cancer Center

Dean W. Lim, M.D.

Clinical Professor, Department of Medical Oncology & Therapeutics Research; Medical Oncologist
Clinical Expertise
Research Focus
  • GI & H&N Cancers
Other Languages Spoken
  • Fookien
  • Mandarin
  • Tagalog

Clinical Teams

Part of the City of Hope team since 1999, Dean W. Lim, M.D., says he still gets emotional when he's able to tell patients their cancer is in remission. “The patient will tear up... they're speechless.... they're just happy... I feel like crying with the patient too!”
 
Educated in the Philippines, Dr. Lim completed a fellowship in Hematology/Oncology at St. Luke's Roosevelt Hospital in New York City before arriving in California some 25 years ago. Well-versed in all aspects of oncology, he specializes in the treatment of head and neck cancer.

Locations

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

Lim D, Akman S, Margolin K, Carr BI, Leong L, Odujinrin O, Morgan RJ Jr, and Doroshow JH. Phase I trial of synkayvite (Vitamin K3, Menadiol Diphosphate) in advanced malignancy. Invest. New Drugs 23: 235-239, 2005.

Chow WA, Synold TW, Tetef ML, Longmate J, Frankel P, Lawrence J, Al-Kadhimi Z, Leong L, Lim D, Margolin K, Morgan RJ, Jr, Raschko J, Shibata S, Somlo G, Twardowski P, Yen Y, and Doroshow JH. Feasibility study of concurrent infusional dexrazoxane and dose-intensive doxorubicin administered over 96 hours for the treatment of advanced malignancies. Cancer Chemother. Pharmacol. 54: 241-248, 2004.

Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R Jr, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Damon L, and Doroshow JH. Prognostic indicators and survival in 120 patients with stage IIIB inflammatory breast carcinoma following dose-intense chemotherapy. J. Clin. Oncol. 22: 1839-1848, 2004.

Morgan RJ, Doroshow JH, Synold T, Lim D, Shibata S, Margolin K, Schwarz R, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Lin P, Paz B, Chu D, Frankel P, and Stalter S. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies confined to the peritoneal cavity: Dose-limiting toxicity and pharmacokinetics. Clin. Cancer Res. 9: 461-467, 2004.

Shibata S, Frankel P, Leong L, Lim D, Margolin K, Morgan R, Somlo G, Synold T, Twardowski P, Doroshow JD. Phase I study of cisplatin (CDDP) in combination with ICRF-187 (ICRF) in the treatment of advanced malignancies. Proc. Amer. Soc. Clin. Oncol. 22: 164, 2003.

Morgan, R.J., Doroshow, J.H., Synold, T., Lim, D., Shibata, S., Margolin, K.A., Schwarz, R., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Lin, P., Paz, B., Chu, D., Frankel, P. and Stalter S. Phase I trial of intraperitoneal (ip) docetaxel (D) in the treatment of advanced malignancies primarily confined to the peritoneal cavity: Dose-limiting toxicity (DLT) and pharmacokinetics (PK). Proc. Amer. Assoc. Cancer Res. 43: 551, #2741, 2002.

Doroshow JH, Margolin K, Chow W, Leong L, Lim D, McNamara M, Morgan R, Shibata S, Somlo G, Twardowski P, Weitzel J, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S. High-dose chemotherapy with autologous stem cell rescue (PSCT) for relapsed nonseminomatous germ cell cancer (NSGCT): Effective salvage for poor-risk patients (pts) in first relapse. Proc. Amer. Soc. Clin. Oncol 21: 179a, # 714, 2002.

Newman EM, Longmate JA, Lenz H.-J, Carroll MI, Stalter SK, Lim D, Raschko JW, Shibata SI, Somlo G, Doroshow JH. Phase I and pharmacokinetic evaluation of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine: a California Cancer Consortium study. Proc. Amer. Soc. Clin. Oncol. 21: 108a, #431, 2002.

Morgan R, Doroshow J, Synold T, Lim D, Shibata S, Margoln K, Schwarz R, Leong L, Somlo G, Twardowski P, Yen Y, Chow W, Lin P, PazB, Chu D, Frankel P. Phase I trial of intraperitoneal Iip) doecetaxel (D) in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Proc. Amer. Soc. Clin. Oncol. 20: 93b, 2001.

Shibata S, Chow W, Frankel P, Leong L, Lim D, Longmate J, Margolin K, McNamara M, Morgan R, Raschko J, Somlo G, Synold T, Tetef M, Twardowski P, Yen Y, Doroshow J, Lenz H, Gandara D. A phase I trial of oxaliplatin (OX) in combination with gemcitabine (G): A California Consortium Trial. Proc. Amer. Soc. Clin. Oncol. 20: 96a, 2001

In The News
An Expert's Voice
Artist Joe Bravo Turns His Cancer Experience Into Art

Bravo, Joe

City of Hope News

Second Fred Claire Celebrity Golf Classic Benefiting City of Hope to Take Place at Oakmont Country Club, Aug. 20

Artist Joe Bravo Turns His Cancer Experience Into Art

Now Recovered from Tongue Cancer, Joe Bravo is Using His Illness to Create Art